Jump to content
  • Sign Up

Archived

This topic is now archived and is closed to further replies.

Scott Adams

Abbvie, Alvine To Collaborate On Investigational Oral Therapy For Celiac Disease - Nasdaq

Recommended Posts

AbbVie, Alvine To Collaborate On Investigational Oral Therapy For Celiac Disease

NASDAQ

Celiac disease is the most common autoimmune disease, affecting approximately 6 million people in the U.S. and E.U. Celiac disease is an acquired autoimmune disorder that develops in genetically susceptible individuals after exposure to dietary gluten ...

View the full article

Share this post


Link to post
Share on other sites

×
×
  • Create New...